| WD05R9E |
4-oxo-4-(3-oxo-3,4-dihydro-2h-1,4-benzoxazin-6-yl)-2-butenoic acid |
26518-87-6 |
Detail |
| WD05R9F |
2-Hydroxyethyl-benzyl sulphide |
26524-88-9 |
Detail |
| WD05R9G |
1,2-diphenyl-pyrazolidine-3,5-dione |
2652-77-9 |
Detail |
| WD05R9H |
1-benzyl-1h-1,3-benzimidazol-5-amine |
26530-89-2 |
Detail |
| WD05R9I |
Cdk4 Inhibitor III |
265312-55-8 |
Detail |
| WD05R9J |
5-Methoxy-2-methylbenzo[d]thiazole-4,7-dione |
265312-60-5 |
Detail |
| WD05R9K |
3-[2-Oxo-3-(trifluoromethyl)pyridin-1(2H)-yl]propanethioamide |
265314-18-9 |
Detail |
| WD05R9L |
(4-tert-butoxycarbonylamino-phenyl)-[(9h-fluoren-9-ylmethoxycarbonylamino)]-acetic acid |
265321-13-9 |
Detail |
| WD05R9M |
2-cyclopropyl-4-pyrimidinamine |
265324-26-3 |
Detail |
| WD05R9N |
Ethyl 2-chloro-6-methylpyrimidine-4-carboxylate |
265328-14-1 |
Detail |